Peter Y. Li

Peter Y. Li

Chief Executive Officer presso Nexcelom Bioscience LLC

Consumer Services
Finance
Health Technology

Profilo

Dr. Peter Li, who joined Ampersand as an Executive Advisor in 2022, has over 25 years of experience in life science tools.
Peter served as President and CEO of Ampersand portfolio company Nexcelom Bioscience, a developer and marketer of image cytometry products for cellular analysis, from 2006 until Nexcelom’s sale to PerkinElmer in 2021.
Prior to Nexcelom, Peter held roles of increasing responsibility at SRU Biosystems, Kodak, Imation, and 3M.
Peter is the Co-Founder and current CEO of Conifer Life Sciences Group, a Boston based firm fostering development of new ventures in the life science tools industry.
Peter is also a Member of the Launchpad Venture Group and a mentor at MIT.
Peter holds a Ph.D.
in Physics from Purdue University and a B.S.
in Physics from Peking University.

Posizioni attive di Peter Y. Li

SocietàPosizioneInizio
Chief Executive Officer 01/01/2006
Consultant / Advisor 01/01/2022
Tutte le posizioni attive di Peter Y. Li

Precedenti posizioni note di Peter Y. Li

SocietàPosizioneFine
SRU Biosystems, Inc. Director/Board Member 01/01/2006
Vedi nel dettaglio l'esperienza di Peter Y. Li

Formazione di Peter Y. Li

Peking University Undergraduate Degree
Purdue University Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Peter Y. Li

Relazioni

100 +

Relazioni di 1° grado

5

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private3

Finance

SRU Biosystems, Inc.

Health Technology

Vedi le connessioni aziendali